(MNTA)—US Humira sales had an annualized run rate of $11.5B, +23.5% YoY, during 4Q16. The 23.5% YoY growth rate consisted of 14% growth in unit volume and 9.5% growth in price. (This does not take into account the additional 8.4% price increase in Jan 2017 [#msg-127963218].)